1245
270
137
85
85
72
72
58
54
48
45
42
42
42
36
36
30
30
29
28
28
28
24
22
22
21
21
19
17
16
15
15
15
14
13
13
12
12
12
12
12
12
11
11
11
10
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
10149
1014
2799
279
3469
346
J CLIN ONCOL
RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine
PDF的下载单位、IP信息已删除
(2025-6-4)